Black Book report finds the market is shifting from stand-alone alerts to enterprise-scale AI platforms that combine clinically credible detection, workflow orchestration, mobile care coordination, ...

Collaboration leverages Imagene's OI Suite, powered by CanvOI and a large-scale multimodal real-world data lake, alongside Composite Continuous Scoring to strengthen biomarker-driven decisions. MIAMI, ...

UPPSALA, SE / ACCESS Newswire / April 9, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB today announced that it has secured strategic contracts to supply hospitals within one of the world's ...

The global Biosurgery Market is expected to expand at a compound annual growth rate (CAGR) of approximately 5% between 2025 ...

TOKYO - April 9, 2026 - Asahi Kasei Microdevices Corporation (AKM), in collaboration with the Kyoto University Institute for Advanced Study, has successfully achieved laser oscillation in a 2 µm-band ...

PharmNovo AB announces that the drug product for its lead candidate PN6047 has been manufactured for the upcoming Phase IIa proof-of-concept (PoC) study in neuropathic pain.PharmNovo is a ...

Scandinavian Real Heart AB (publ) announces today that the company’s artificial heart technology, its founder and inventor Dr. Azad Najar, and long-standing clinical research collaborator Professor ...

Dental Practice Management Software Market OverviewThe global dental practice management software market is witnessing steady ...

The Digital Therapeutics (DTx) Market sector is undergoing rapid expansion, with forecasts indicating a compound annual ...

Neurodiagnostics Market OverviewThe Neurodiagnostics Market is anticipated to grow at a steady rate of 7–8% between 2023 and 2028, supported by continuous innovation and rising clinical demand. The ...

First patient dosed in France, expanding the DOMISOL study beyond Australia ·       DT‑7012 is being evaluated as monotherapy and in combination with pembrolizumab in a global clinical development ...

GOTHENBURG, SE / ACCESS Newswire / April 9, 2026 / IRLAB Therapeutics AB (STO:IRLAB-A)(FRA:6IRA), a company discovering and developing novel treatments for Parkinson's disease, today announced that ...